Energy contracts VG BioProcess algae to verify “lipid trigger” Results for the production of biofuels trade
San Marino, CA (PRWEB) March 25, 2011
VG Energy, a subsidiary of Viral Genetics, Inc. (PINKSHEETS: VRAL), announced today that it has withheld from Other energy producer BioProcess algae, LLC to verify the results of large-scale laboratory for the development of commercial production of its process of biofuel potential. VG Energy has developed a proprietary technology, with results reproduced several times in test tube studies of the small pond, which appears promising in the production of biofuels from algae on a commercial scale at competitive prices with or better than current oil prices.
VG energy technology has shown promise as an additive for viable and profitable alternative energy sources, “said Haig Keledjian, CEO of VG Energy and viral genetic . “We are delighted to work with BioProcess algae to take the next step and move from the laboratory to put into production viable.”
The agreement came together quickly and was facilitated by VG energy SVP Monica Ord. “I Richard Branson of Virgin and Mike Willis Green to thank for the introduction of Green Plains Renewable Energy (GPRE) and BioProcess algae,” said Ord. “We reiterated our statement of research studies leading to several occasions, both internally and by the Texas A & M, which have clearly demonstrated the efficacy of the compound on a small scale. Bioprocess algae gives us the ability to move quickly in the middle of autotrophic, mixotrophic and heterotrophic scale studies, and we are anxious to begin. “
process more lipid production in algae cells and dramatically improving their recyclability rate
Was discovered by VG Energy and its principal investigator, Dr. M. Karen Newell Rogers, Raleigh R. White, Jr. Endowed Professor of Surgery Research at Texas A & M Health Science Center and Scott and White Hospital Temple, Texas. A recent report of biofuels expert John Sheehan several models present production techniques, with improved productivity through the process of LV energy, with results showing the potential of a profitable energy source. A direct result of work undertaken by Dr. Newell Rogers for the treatment of cancer, metabolic disturbance process technology (MDT), appears to act as a trigger lipid long sought to cause the algae cells to store increased fat This makes them more productive as an energy source. When the process was applied to the algae cells in the laboratory, extractable lipids, or fat production increased by a minimum of 300%. In addition, the process allows fat cells to release outside the cell walls, making the most recyclable and algae increases its viability as an alternative energy source.
About VG
energy
VG Energy Inc. is an energy company and the replacement of agricultural biotechnology, which is a majority owned subsidiary of Viral Genetics Inc., a biotechnology company researching new treatments and methods for detecting diseases, including cancer, HIV / AIDS and others. Through its technology disruption of metabolism (MDT), Cancer Research Genetics Viral led to discoveries with important consequences in a wide variety of other industries, including vegetable oils and biofuels. VG Energy holds the exclusive worldwide license to patent rights for use in PCT increased production of various vegetable oils from algae and seeds. These pivotal discoveries promise to enable the biofuels industry to overcome its major obstacle in the field of production efficiency: namely, increased production efficiencies resulting in possible economic return on investment, allowing biodiesel to be competitive renewable with fossil fuels. For more information, please visit http://www.vgenergy.net.
BioProcess
on algae, LLC
BioProcess algae, LLC (GAP) was created in 2008 to commercialize algae production systems for next-generation biofuels and feed. GAP technology and manufacturing headquarters are based in Portsmouth, Rhode Island and demonstration efforts are integrated with an ethanol plant owned 65 MGPY Green Plains Renewable Energy in Shenandoah, IA. BPA is a joint venture between CLARCOR, BioProcessH2O LLC Green Plains Renewable Energy, Inc., and NTR plc. More information can be found at http://www.bioprocessalgae.com.
About
viral genetics, Inc.
San Marino, California, discovered viral gene therapies. Founded in 1994, the biotechnology company is looking for treatments against HIV / AIDS drug against tumors, LymeDisease, Strep, Staph and durable. A majority-owned subsidiary, VG Energy (http://www.vgenergy.net), is dedicated to exploring the application of biofuels and agriculture for a technology license in his wallet. For more information, visit http://www.viralgenetics.com.
REFUGE FOR FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, deadlines stage clinical development, regulatory approvals and other risks described by Viral Genetics, Inc. from time to time in its periodic reports. None of Viral Genetics pharmaceutical compounds are approved by the U.S. Food and Drug Administration or any comparable regulatory agencies elsewhere in the world. Although the viral genetic believes that such statements and assumptions underlying reasons, one of the assumptions could be inaccurate, including, without limitation, the ability of Viral Genetics to establish the commercial relevance of relaxation of lipids, or efficacy of any of his medication in the treatment of any disease or health, development studies and strategies leading to commercialization of pharmaceutical compounds in the United States, obtaining funding required to carry out development plans, completion of studies and tests on time or at all, and the success of such studies or tests. Therefore, there can be no assurance that such statements included in this release will prove accurate. In light of significant uncertainties inherent in forward-looking statements included in this document, such statements should not be regarded as a representation by Viral Genetics or any other person that the objectives and plans of Viral Genetics will be achieved.
>
clear = “all”
class = “small-text”>
© Copyright 1997 -
, Vocus PRW Holdings, LLC.
Vocus, PRWeb and advertising Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Comments are closed.